|
MTF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.356500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.915200E-03 |
| Normal-vs-Stage2 |
5.018100E-02 |
| Normal-vs-Stage3 |
2.550000E-01 |
| Normal-vs-Stage4 |
1.820760E-01 |
| Stage1-vs-Stage2 |
5.581000E-01 |
| Stage1-vs-Stage3 |
3.351200E-01 |
| Stage1-vs-Stage4 |
6.329000E-01 |
| Stage2-vs-Stage3 |
2.676800E-01 |
| Stage2-vs-Stage4 |
9.774000E-01 |
| Stage3-vs-Stage4 |
3.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.992700E-04 |
| Normal-vs-AfricanAmerican |
1.636430E-02 |
| Normal-vs-Asian |
4.475700E-02 |
| Caucasian-vs-AfricanAmerican |
5.637600E-01 |
| Caucasian-vs-Asian |
7.870600E-01 |
| AfricanAmerican-vs-Asian |
6.331400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.573800E-04 |
| Normal-vs-Female |
2.024100E-03 |
| Male-vs-Female |
8.279400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.036100E-02 |
| Normal-vs-Extreme_Weight |
3.591800E-02 |
| Normal-vs-Obese |
4.222900E-03 |
| Normal-vs-Extreme_Obese |
8.742200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.300200E-01 |
| Normal_Weight-vs-Obese |
8.808800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.978600E-01 |
| Extreme_Weight-vs-Obese |
3.734600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.194000E-01 |
| Obese-vs-Extreme_Obese |
8.209400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.036600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.96800000000064E-05 |
| Normal-vs-Age(61-80Yrs) |
3.557400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.665800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.577200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.812800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.124000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.424820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.056400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.792000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.10389999996574E-06 |
| Normal-VS-Type2 PRCC |
9.329000E-01 |
| Normal-VS-KIRP CIMP |
3.459400E-01 |
| Normal-VS-Unclassified PRCC |
2.227600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.10289999968971E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.243000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.051800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.885560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.778420E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.717810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.169180E-01 |
| Normal-vs-N1 |
1.708500E-02 |
| Normal-vs-N2 |
4.877800E-01 |
| N0-vs-N1 |
1.328800E-01 |
| N0-vs-N2 |
9.884400E-01 |
| N1-vs-N2 |
5.142200E-01 |
|
|
